It has been shown that IL3RA (IL3 receptor alpha) is highly expressed in AML cells [52] and can be targeted using an anti-CD123 monoclonal antibody in CML blast cells [53]. Here, IL3RA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.